Orikine Bio
Edgardo Ferran is a distinguished professional in the fields of biotechnology, bioinformatics, and translational sciences, currently serving as a Member of the Board of Directors at Orikine Bio since November 2023, focusing on engineered cytokines for immune-mediated diseases. Ferran has held significant roles including Board Director at Pulmobiotics from May 2020 to January 2023 and Consultant positions at EMBL-EBI and the Centre for Genomic Regulation from 2014 to 2022. With a comprehensive background at Sanofi from 1990 to 2014 as Head of Bioinformatics & Systems Biology, and expertise in projects related to tuberculosis at CNRS, Ferran brings over three decades of experience in integrating computing sciences with biological research. Educational credentials include a PhD in Physics from Universidad de Buenos Aires, along with advanced degrees in Physics and Engineering.
This person is not in any teams
This person is not in any offices
Orikine Bio
Orikine Bio is a pioneering biotech company dedicated to advancing the field of engineered cytokines with unparalleled biological features for the treatment of immune-mediated diseases. Our core mission is to unlock the untapped potential of cytokines, enabling us to offer transformative therapies that have the power to reshape the lives of patients around the globe.